Stereotaxis, Inc. 

(Public, NASDAQ:STXS)   Watch this stock   
Find more results for STXS
Nov 5, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -43.74% -108.73%
Operating margin -31.92% -101.62%
EBITD margin - -95.71%
Return on average assets -55.26% -73.20%
Return on average equity - -303.02%
Employees 183 -

Address

4320 Forest Park Avenue Suite 100
St. Louis, MO 63108
United States - Map
+1-314-6786100 (Phone)
+1-314-6156938 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Stereotaxis, Inc. discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Stereotaxis, Inc. discussions

  View all discussions »

Description

Stereotaxis, Inc., designs, manufactures and markets cardiology instrument control system for use in a hospital’s interventional medical suite, or interventional lab, for the treatment of arrhythmias and coronary artery disease by enabling therapeutic solutions and existing catheter-based, or interventional, procedures. Its Niobe system allows physicians to navigate catheters, guidewires and other delivery devices through the blood vessels and chambers of the heart to treatment sites to effect treatment. The Company’s Odyssey Total Information Solution allows physicians to utilize a consolidated user interface and single mouse and keyboard control for multiple systems within the interventional lab.

Officers and directors

Fred A. Middleton
Chairman of the Board
Age: 59
Bio & Compensation - Reuters
Michael P. Kaminski
President, Chief Executive Officer, Director
Portrait. Age: 49
Bio & Compensation - Reuters
Daniel J. Johnston CPA
Chief Financial Officer
Age: 51
Bio & Compensation - Reuters
Melissa C. Walker
Senior Vice President - Regulatory, Quality and Compliance
Age: 52
Bio & Compensation - Reuters
Louis T. Ruggiero
Senior Vice President, North America and Chief Commercial Officer
Age: 49
Bio & Compensation - Reuters
Douglas Michael Bruce
Chief Technology Officer, Chief Operations Officer
Age: 51
Bio & Compensation - Reuters
Bevil J. Hogg
Director
Portrait. Age: 60
Bio & Compensation - Reuters
Christopher Alafi Ph.D.
Director
Age: 45
Bio & Compensation - Reuters
William M. Kelley
Director
Age: 73
Bio & Compensation - Reuters
Abhijeet J. Lele
Director
Age: 43
Bio & Compensation - Reuters